MEDEZE Showcases Advanced Medical Innovation and Biobank Solutions for Women’s Health at OBGYN in Practice 2026
Dr. Veerapol Khemarangsan, Chief Executive Officer, and Ms. Danita Phithaknetikun, Chief Business Development Officer, of Medeze Group Public Company Limited, or MEDEZE, participated in the exhibition booth to present information on the company’s products and services related to stem cells, biobanking, and advanced medical innovations at the academic conference “OBGYN in Practice 2026.” The conference was held under the theme “Power of Love in Women’s Care: From Many Hands to One Heart” from 11–13 February 2026 at the Tripetch Conference Room, 15th Floor, the 100 Years Somdech Phra Srinagarindra Building, Siriraj Hospital.
On this occasion, the company also delivered a lecture titled “Update Stem Cell Regulation and Trend in Biobank and Regenerative Medicine,” sharing insights and updates on regulatory developments in stem cell technology, trends in biobank development, and advancements in regenerative medicine that play a significant role in women’s healthcare today and in the future.
The session was conducted in collaboration with Dr. Pornthep Siriwanarangsan, President of the Preventive Medicine Association of Thailand, who shared policy perspectives and regulatory trends regarding advanced medical products. The discussion reflected strong collaboration between the academic sector and the private sector in advancing medical standards in line with the rapid evolution of modern medical technology.
The session was moderated by Prof. Dr. Tuangsit Wataganara, Chairman of the Fetal Treatment Center, who facilitated an engaging and insightful knowledge exchange, along with an open forum for in-depth questions and discussions. The session attracted strong interest and active participation from conference attendees.
For more information, please visit: https://www.medezegroup.com/th/
IR Press Releases